Joshua Silverman, CEO and President of PharmaCyte Biotech, Inc. ($PMCB), made three open market purchases of company shares over the past year, totaling about $80,500. His most recent buy occurred on January 7, 2026. These purchases rank 2,578th out of 4,983 individual insiders in our database by dollar amount, well below the average of $1.5 million across 3.3 transactions. Silverman reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | PharmaCyte Biotech, Inc. | $PMCB | Silverman Joshua | CEO and President | P | Common Stock | 40000 | $0.83 | 466,250.0000 | 10,134,160 | 9.38% | 0.39% |
| Jan. 6, 2026 | PharmaCyte Biotech, Inc. | $PMCB | Silverman Joshua | CEO and President | P | Common Stock | 30000 | $0.79 | 426,250.0000 | 10,134,160 | 7.57% | 0.30% |
| Jan. 5, 2026 | PharmaCyte Biotech, Inc. | $PMCB | Silverman Joshua | CEO and President | P | Common Stock | 30000 | $0.78 | 396,250.0000 | 10,134,160 | 8.19% | 0.30% |
| Jan. 2, 2026 | Petros Pharmaceuticals, Inc. | $PTPI | Silverman Joshua | Director | A | Common Stock | 4375000 | $0.00 | 4,415,450.0000 | 42,284,502 | 9999.99% | 10.35% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | Silverman Joshua | CEO and President | A | Common Stock | 575000 | $0.00 | 625,000.0000 | 6,795,779 | 1150.00% | 8.46% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | Silverman Joshua | CEO and President | F | Common Stock | 258750 | $1.02 | 366,250.0000 | 6,795,779 | 41.40% | 3.81% |
| Nov. 14, 2025 | Q/C TECHNOLOGIES, INC. | $QCLS | Silverman Joshua | Executive Chairman | A | Common stock | 91356 | $0.00 | 100,029.0000 | 10,132,619 | 1053.34% | 0.90% |
| Oct. 31, 2025 | StableX Technologies, Inc. | $SBLX | Silverman Joshua | Chief Executive Officer | A | Employee Stock Option (Right to Buy | 220513 | $0.00 | 220,513.0000 | 8,541,466 | 9999.99% | 2.58% |
| Oct. 17, 2025 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Executive Chairman | F | Common Stock, par value $0.0001 per share | 40000 | $7.23 | 86,681.0000 | 2,549,600 | 31.58% | 1.57% |
| Oct. 17, 2025 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Executive Chairman | A | Common Stock, par value $0.0001 per share | 100000 | $0.00 | 126,681.0000 | 2,549,600 | 374.80% | 3.92% |
| Aug. 6, 2025 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Executive Chairman | A | Employee Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 1,565,200 | 9999.99% | 2.30% |
| Oct. 3, 2025 | Q/C TECHNOLOGIES, INC. | $QCLS | Silverman Joshua | Executive Chairman | A | Common stock | 8644 | $0.00 | 8,673.0000 | 10,132,619 | 9999.99% | 0.09% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Executive Chairman | A | Common Stock, par value $0.0001 per share | 41919 | $0.00 | 43,449.0000 | 1,392,881 | 2739.80% | 3.01% |
| June 30, 2025 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Executive Chairman | F | Common Stock, par value $0.0001 per share | 16768 | $7.85 | 26,681.0000 | 1,392,881 | 38.59% | 1.20% |
| June 25, 2025 | FEMASYS INC | $FEMY | Silverman Joshua | Not found | A | Stock Option (Right to Buy) | 17600 | $0.00 | 17,600.0000 | 27,149,971 | 9999.99% | 0.06% |
| Feb. 19, 2025 | Petros Pharmaceuticals, Inc. | $PTPI | Silverman Joshua | Director | A | Common Stock | 1000000 | $0.00 | 1,011,237.0000 | 8,026,038 | 8899.17% | 12.46% |
| Dec. 2, 2024 | StableX Technologies, Inc. | $SBLX | Silverman Joshua | Executive Chairman | M | Cash-Settled Restricted Stock Units | 97368 | $0.00 | 97,368.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | StableX Technologies, Inc. | $SBLX | Silverman Joshua | Executive Chairman | A | Common Stock | 146052 | $0.00 | 189,323.0000 | 0 | 337.53% | 0.00% |
| Dec. 2, 2024 | StableX Technologies, Inc. | $SBLX | Silverman Joshua | Executive Chairman | D | Common Stock | 6166 | $0.00 | 43,271.0000 | 0 | 12.47% | 0.00% |
| July 12, 2024 | FEMASYS INC | $FEMY | Silverman Joshua | Not found | A | Stock Option (Right to Buy) | 17600 | $0.00 | 17,600.0000 | 0 | 9999.99% | 0.00% |
| April 8, 2024 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Director | A | Stock Option (Right to Buy) | 800 | $0.00 | 800.0000 | 1,036,700 | 9999.99% | 0.08% |
| Nov. 21, 2023 | FEMASYS INC | $FEMY | Silverman Joshua | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 0 | 9999.99% | 0.00% |
| March 29, 2023 | TAO Synergies Inc. | $TAOX | Silverman Joshua | Director | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 6,989,200 | 9999.99% | 0.29% |